Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.23.2
Consolidated Balance Sheets - USD ($)
Jul. 31, 2023
Oct. 31, 2022
CURRENT ASSETS    
Cash and Cash Equivalents $ 24,890,568 $ 22,927,371
Accounts Receivable, net 2,509,425 2,870,600
Inventory 11,647,639 10,027,111
Unbilled Receivables 1,742,334 602,115
Prepaid Expenses 570,079 240,464
Other Current Assets 372,183 343,061
Total Current Assets 41,732,228 37,010,722
FIXED ASSETS    
Property and Equipment, net 6,251,246 5,832,532
OTHER ASSETS    
Goodwill and Other Intangibles, net 3,853,545 3,824,394
Deferred Tax Asset 132,776 259,810
Total Other Assets 3,986,321 4,084,204
Total Assets 51,969,795 46,927,458
CURRENT LIABILITIES    
Accounts Payable 1,126,762 793,247
Accrued Expenses and Other Current Liabilities 225,787 1,731,706
Deferred Revenue 640,775 943,569
Total Current Liabilities 1,993,324 3,468,522
LONG TERM LIABILITIES    
Deferred Revenue, less current portion 139,242 76,127
Total Liabilities 2,132,566 3,544,649
STOCKHOLDERS’ EQUITY    
Common Stock, $.001 par value; 150,000,000 shares authorized, 11,117,695 issued and outstanding as of July 31, 2023 and 10,916,853 shares issued and outstanding as of October 31, 2022 11,118 10,918
Treasury Stock (46,300) (28,337)
Additional Paid-in Capital 62,802,551 62,313,988
Accumulated Other Comprehensive Loss (2,198,618) (4,737,124)
Accumulated Deficit (10,731,522) (14,176,636)
Total Stockholders’ Equity 49,837,229 43,382,809
Total Liabilities and Stockholders’ Equity $ 51,969,795 $ 46,927,458